These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38300900)

  • 41. BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.
    Waters L; Winston A; Reeves I; Boffito M; Churchill D; Cromarty B; Dunn D; Fink D; Fidler S; Foster C; Fox J; Gupta R; Hilton A; Khoo S; Leen C; Mackie N; Naous N; Ogbonmwan D; Orkin C; Panton L; Post F; Pozniak A; Sabin C; Walsh J
    HIV Med; 2022 Dec; 23 Suppl 5():3-115. PubMed ID: 36504313
    [No Abstract]   [Full Text] [Related]  

  • 42. Transmission and pathogenesis of human immunodeficiency virus type 1.
    Connor RI; Ho DD
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):321-3. PubMed ID: 8068409
    [No Abstract]   [Full Text] [Related]  

  • 43. For human immunodeficiency virus disease, more treatment seems to be better: comment on "Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion".
    Katz MH
    Arch Intern Med; 2012 Sep; 172(16):1256. PubMed ID: 22824829
    [No Abstract]   [Full Text] [Related]  

  • 44. HIV-1-Associated Kidney Disease in an Elite Controller.
    Charre C; Lemoine S; Icard V; Maud R; Tardy JC; Chiarello P; Godinot M; Avettand-Fenoel V
    AIDS Patient Care STDS; 2022 Nov; 36(11):413-415. PubMed ID: 36301263
    [No Abstract]   [Full Text] [Related]  

  • 45. [Expanded epidemiological data census in HIV].
    Schweiz Monatsschr Zahnmed; 1992; 102(9):1123, 1151. PubMed ID: 1455210
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of primary HIV infection: new data for a new era.
    Conway B
    AIDS; 2020 Oct; 34(12):1855-1856. PubMed ID: 32889855
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term follow-up of subjects with an indeterminate HIV-2 western blot.
    Pepin J; Dalby M; Gaye I; Berry N; Whittle H
    AIDS; 1991 Oct; 5(10):1274-5. PubMed ID: 1786162
    [No Abstract]   [Full Text] [Related]  

  • 48. HIV-1 in Taiwan.
    Chen YM; Kuo SH
    Lancet; 2007 Feb; 369(9562):623-5. PubMed ID: 17321295
    [No Abstract]   [Full Text] [Related]  

  • 49. Milestones: Dr. Robert C. Gallo and the Discovery of HIV-1.
    Lusso P
    Curr HIV Res; 2023; 21(1):2-5. PubMed ID: 37493081
    [No Abstract]   [Full Text] [Related]  

  • 50. Inference of HIV-1 transmission direction between men who have sex with men (MSM) and their wives in China.
    Zhou Z; Feng Y; Ou W; Zhang D; Su R; Cao Y; Zheng H; Ma P; Wei M; Shao Y
    AIDS; 2023 May; 37(6):1015-1017. PubMed ID: 37017025
    [No Abstract]   [Full Text] [Related]  

  • 51. Primary HIV-1 infection.
    N Engl J Med; 1991 Sep; 325(10):733-5. PubMed ID: 1831246
    [No Abstract]   [Full Text] [Related]  

  • 52. High viremia in HIV-1 subtype C infection and spread of the epidemic.
    Neogi U; Palchaudhuri R; Shet A
    J Infect Dis; 2013 Sep; 208(5):866-7. PubMed ID: 23757339
    [No Abstract]   [Full Text] [Related]  

  • 53. HTLV-II does not adversely affect the natural history of HIV-1 infection in intravenous drug users.
    Magnani G; Elia G; Casoli C; Calzetti C; Degli Antoni A; Fiaccadori F
    Infection; 1995; 23(1):63. PubMed ID: 7744497
    [No Abstract]   [Full Text] [Related]  

  • 54. Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 Assembly.
    Reed JC; Solas D; Kitaygorodskyy A; Freeman B; Ressler DTB; Phuong DJ; Swain JV; Matlack K; Hurt CR; Lingappa VR; Lingappa JR
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33148797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody and T-cell responses elicited by coronavirus disease 2019 vaccination in people with HIV-1: the case of late presenters.
    Ahmad A; Samarani S; Costiniuk CT
    AIDS; 2023 Aug; 37(10):1625-1627. PubMed ID: 37450628
    [No Abstract]   [Full Text] [Related]  

  • 56. Dolutegravir and rilpivirine as successful initial antiretroviral therapy in a treatment-naive patient with HIV-1: A case report.
    Zafar SJ; Gilliam BL; Schmalzle SA
    Antivir Ther; 2023 Dec; 28(6):13596535231218875. PubMed ID: 38048138
    [No Abstract]   [Full Text] [Related]  

  • 57. Viral, cellular and immune aspects of non-suppressible HIV-1 viremia.
    Nat Med; 2023 Dec; 29(12):3016-3017. PubMed ID: 37996710
    [No Abstract]   [Full Text] [Related]  

  • 58. Role of microglia in HIV-1 infection.
    Bai R; Song C; Lv S; Chang L; Hua W; Weng W; Wu H; Dai L
    AIDS Res Ther; 2023 Mar; 20(1):16. PubMed ID: 36927791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No evidence of HIV-2 infection amongst HIV-1 Ab positive people in the largest cities of north-eastern Italy.
    Costigliola P; Ricchi E; Manfredi R; Tumietto F; Barelli A; Borri A; De Rosa V; Chiodo F
    Eur J Epidemiol; 1992 Jan; 8(1):140-1. PubMed ID: 1572425
    [No Abstract]   [Full Text] [Related]  

  • 60. Acanthosis nigricans in an HIV seropositive: is there a correlation?
    Marfatia YS; Sharma A
    Indian J Dermatol Venereol Leprol; 2006; 72(5):383-4. PubMed ID: 17050939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.